Biogen’s Newly Approved Alzheimer’s Drug Ships in 2 Weeks. The Confirmatory Trial Will Take 8 Years.
source: pixabay.com

Biogen’s Newly Approved Alzheimer’s Drug Ships in 2 Weeks. The Confirmatory Trial Will Take 8 Years.

  The pressure was on. Researchers had been studying Alzheimer’s for decades. Every morsel of discovery was hailed as moving closer to a cure and results were always expected soon…

Continue Reading Biogen’s Newly Approved Alzheimer’s Drug Ships in 2 Weeks. The Confirmatory Trial Will Take 8 Years.
Study of the Week: Addressing Tendinopathy in Osteogenesis Imperfecta
source: pixabay.com

Study of the Week: Addressing Tendinopathy in Osteogenesis Imperfecta

Welcome to Study of the Week from Patient Worthy. In this segment, we select a study we posted about from the previous week that we think is of particular interest…

Continue Reading Study of the Week: Addressing Tendinopathy in Osteogenesis Imperfecta

Axial PsA and axSpA Patient Populations are Found to Have Key Similarities and Differences

A recent study presented in early June showcased how, despite some similarities, psoriatic arthritis with axial involvement (axial PsA) patients and axial spondyloarthritis (axSpA) patients have meaningful differences. These findings…

Continue Reading Axial PsA and axSpA Patient Populations are Found to Have Key Similarities and Differences

Study Finds Treatment for Pulmonary Fibrosis Effective in Later Stages of Disease

University of Illinois Researchers have uncovered novel information about pulmonary fibrosis. Their research demonstrates that fibrosis in the lungs can be reversed, and tissue can be repaired using microgel-coated mesenchymal…

Continue Reading Study Finds Treatment for Pulmonary Fibrosis Effective in Later Stages of Disease